US68620A2033 - Common Stock
ORGANOVO HOLDINGS INC
NASDAQ:ONVO (5/15/2024, 7:00:23 PM)
After market: 1 -0.03 (-2.91%)1.03
+0.04 (+4.04%)
Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. The company is headquartered in San Diego, California and currently employs 15 full-time employees. The company went IPO on 2013-08-02. The firm uses these models to identify gene targets responsible for driving the disease and intends to initiate drug discovery programs around these validated targets. The company is initially focusing on the intestine and has ongoing 3D tissue development efforts in ulcerative colitis (UC) and Crohns disease (CD). The firm uses its technology to build functional 3D human tissues that mimic various aspects of native human tissue composition, architecture, function, and disease. Its NovoGen Bioprinters are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. Its NovoGen Bioprinters can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters. Its 3D human tissue platform is multifaceted.
ORGANOVO HOLDINGS INC
Suite 110, 6275 Nancy Ridge Drive
San Diego CALIFORNIA 92075
P: 18585509994
CEO: Keith Murphy
Employees: 15
Website: https://organovo.com/
Renowned gastrointestinal diseases conference to held in Washington, D.C. May 18-21, 2024
Organovo will be presenting data on the Company’s lead clinical-stage drug, FXR314 during DDW2024, which is being held in Washington, D.C. May 18-21, 2024...
Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday!
ONVO announced the pricing of a public offering consisting of 6,562,500 shares of common stock (or pre-funded warrants in lieu thereof)....
Here you can normally see the latest stock twits on ONVO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: